 |
PDBsum entry 1vqx
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1vqx
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
279:51203-51207
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions.
|
|
O.G.Kisselev,
M.A.Downs,
J.H.McDowell,
P.A.Hargrave.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Phosphorylation of activated G-protein-coupled receptors and the subsequent
binding of arrestin mark major molecular events of homologous desensitization.
In the visual system, interactions between arrestin and the phosphorylated
rhodopsin are pivotal for proper termination of visual signals. By using high
resolution proton nuclear magnetic resonance spectroscopy of the phosphorylated
C terminus of rhodopsin, represented by a synthetic 7-phosphopolypeptide, we
show that the arrestin-bound conformation is a well ordered helix-loop structure
connected to rhodopsin via a flexible linker. In a model of the
rhodopsin-arrestin complex, the phosphates point in the direction of arrestin
and form a continuous negatively charged surface, which is stabilized by a
number of positively charged lysine and arginine residues of arrestin. Opposite
to the mostly extended structure of the unphosphorylated C-terminal domain of
rhodopsin, the arrestin-bound C-terminal helix is a compact domain that occupies
a central position between the cytoplasmic loops and occludes the key binding
sites of transducin. In conjunction with other binding sites, the helix-loop
structure provides a mechanism of shielding phosphates in the center of the
rhodopsin-arrestin complex and appears critical in guiding arrestin for high
affinity binding with rhodopsin.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIG. 4. a, ribbon model of bovine rhodopsin in blue with
phosphorylated C-terminal domain shown in yellow in
arrestin-bound conformation. Side chains of phosphorylated
serines and threonines are shown as ball-and-stick models.
Semi-transparent solvent-accessible surface of the phosphate
groups is shown in red. Position of the transmembrane helices of
rhodopsin is labeled. b, van der Waals surface of rhodopsin
(cytoplasmic side) as seen by arrestin with the electrostatic
potential mapped. White, neutral; red, negatively charged; blue,
positively charged. The phospho-groups on Ser-334, Thr-335,
Thr-336, Ser-338, Thr-340, Thr-342, and Ser-343 together with
carboxyl groups of Glu-332 and Glu-341 form a continuous
negatively charged surface. C2 and C3 show position of
cytoplasmic loops two and three.
|
 |
Figure 5.
FIG. 5. A model of rhodopsin-arrestin complex. Docking of
arrestin to rhodopsin with phosphorylated Rh-(330-348) region in
arrestin-bound state was manual, assuming interaction of the
phosphate groups with region 166-179 of arrestin, a site of
rhodopsin interactions with the most concentration of arginine
and lysine residues. -Strands containing the
region 166-179 and segments determining receptor specificity are
in purple. Inset highlights the interaction site. Phosphate
groups of rhodopsin are shown in red and labeled according to
the phosphorylated residue number. Lysine and arginine side
chains positioned for possible interactions with phosphates are
in blue and labeled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
51203-51207)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.Stadel,
K.H.Ahn,
and
D.A.Kendall
(2011).
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.
|
| |
J Neurochem,
117,
1.
|
 |
|
|
|
|
 |
B.W.Jones,
and
P.M.Hinkle
(2008).
Arrestin binds to different phosphorylated regions of the thyrotropin-releasing hormone receptor with distinct functional consequences.
|
| |
Mol Pharmacol,
74,
195-202.
|
 |
|
|
|
|
 |
K.Werner,
C.Richter,
J.Klein-Seetharaman,
and
H.Schwalbe
(2008).
Isotope labeling of mammalian GPCRs in HEK293 cells and characterization of the C-terminus of bovine rhodopsin by high resolution liquid NMR spectroscopy.
|
| |
J Biomol NMR,
40,
49-53.
|
 |
|
|
|
|
 |
K.Bakshi,
R.W.Mercier,
and
S.Pavlopoulos
(2007).
Interaction of a fragment of the cannabinoid CB1 receptor C-terminus with arrestin-2.
|
| |
FEBS Lett,
581,
5009-5016.
|
 |
|
|
|
|
 |
A.H.Geiser,
M.K.Sievert,
L.W.Guo,
J.E.Grant,
M.P.Krebs,
D.Fotiadis,
A.Engel,
and
A.E.Ruoho
(2006).
Bacteriorhodopsin chimeras containing the third cytoplasmic loop of bovine rhodopsin activate transducin for GTP/GDP exchange.
|
| |
Protein Sci,
15,
1679-1690.
|
 |
|
|
|
|
 |
K.Palczewski
(2006).
G protein-coupled receptor rhodopsin.
|
| |
Annu Rev Biochem,
75,
743-767.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |